| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 4.608 | 4.694 | 4.739 | 6.511 | 6.714 | 6.039 | 7.863 | 9.736 | 11.236 | 11.306 |
| Total Income - EUR | 4.608 | 4.694 | 4.739 | 6.511 | 6.720 | 6.613 | 7.863 | 9.736 | 11.236 | 11.306 |
| Total Expenses - EUR | 4.735 | 5.456 | 5.923 | 6.253 | 6.720 | 6.225 | 7.774 | 8.271 | 9.637 | 10.639 |
| Gross Profit/Loss - EUR | -127 | -762 | -1.185 | 257 | 0 | 388 | 89 | 1.465 | 1.599 | 667 |
| Net Profit/Loss - EUR | -266 | -840 | -1.232 | 192 | -67 | 354 | 89 | 1.465 | 1.487 | 556 |
| Employees | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
Check the financial reports for the company - Docomidaş Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Assets | 123 | 410 | 61 | 535 | 382 | 879 | 537 | 271 | 709 | 1.267 |
| Inventories | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | 0 | 0 | 0 | 0 | 0 | 0 | 13 | 13 | 0 | 0 |
| Cash | 123 | 410 | 61 | 535 | 382 | 879 | 523 | 258 | 709 | 1.267 |
| Shareholders Funds | -1.879 | -2.700 | -3.887 | -3.623 | -3.620 | -3.198 | -3.038 | -1.582 | -91 | 465 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 2.002 | 3.110 | 3.948 | 4.158 | 4.002 | 4.077 | 3.574 | 1.854 | 800 | 883 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "9531 - 9531" | |||||||||
| CAEN Financial Year |
4520
|
|||||||||
Comments - Docomidaş Srl